Research_
Clinical trials
Current and upcoming trials
Browse a list of current, upcoming and previous clinical trials by condition conducted by research groups across the institute.
Current clinical trials
Adenoviral Conjunctivitis
- Ruby - HREC/47911/SVHM-2018
Age-related macular degeneration
- Archer Study (Dry AMD) - CALHN HREC 2021/HRE00112
- FURGGHORN (Wet AMD) - HREC/95605/SVHM-2023-367480
- GALE (Extension of OAKS) - HREC/77051/SVHM-2021-273676
- IONIS (Dry AMD) - HREC/50571/SVHM-2018
- OTX-TKI (Wet AMD) - HREC/52072/SVHM-2019
- PHOENIX (Dry AMD) - HREC/99641/SVHM-2023-378051
- PORTAL (Wet AMD) - HREC/70305/SVHM-2021-264245
- PULSAR (Wet AMD) - HREC/63698/SVHM-2020-213156
- VELODROME (Wet AMD) - HREC/69746/2020-001313-20
Diabetic eye disease
Inherited retinal dystrophies
- Achromatopsia natural history study
- GUCY2D related cone dystrophy natural history study
- Cone-rod dystrophy or cone dystrophy natural history study
- Retinitis Pigmentosa (cone-rod dystrophy) natural history study
- PRPH2 associated retinopathy natural history study
- MERTK associated retinopathy natural history study
- PRPF31 associated retinopathy natural history study
- KCNV2 retinopathy natural history study
- IMPDH1 associated retinopathy natural history study
Inherited retinal disease
- EPIC Vision Study
- Mobility Assessment in Inherited Retinal Diseases using a virtual reality (VR) system - HREC/13962/SESLHD-HREC2020
Macular dystrophies
- Stargardt Disease study
- Stargardt natural history study
- Stargardt (ABCA4) natural history study
- Best disease natural history study
Macular telangiectasia (MacTel)
- MacTel Project - HREC/16/POWH/215
Retinal vein occlusion
- QUASAR - HREC/97356/SVHM-2023-367440
Thyroid Eye Disease
- SatraGO1 – HREC/97790/SVHM-2023
Sub-macular haemorrhage
- SRI - HREC/18/POWH/562
Usher syndrome
- Usher sydrome trial - HREC/57664/SVHM-2019
Uveitis
Completed clinical trials
- HAWK (Wet AMD) - HREC/15/RPAH/167
- RIVAL (Wet AMD) - HREC/13/SHA/46
- FILLY (Dry AMD) - HREC/15/RPAH/394
- CHROMA (Dry AMD) - HREC/14/RPAH/287
- OMASPECT (Dry AMD) - HREC/16/POWH/543
- SEQUOIA (Wet AMD) - HREC/15/RPAH/347
- ARIES (Wet AMD) - HREC/15/RPAH/387
- Talon (Wet AMD) - HREC/53858/SVHM-2019
- PANDA (Wet AMD) - HREC/18/SVHM/251
- LUCERNE (Wet AMD) - HREC/49517/SVHM-2019
- OAKS (Dry AMD) - HREC/18/SVHM/252
- MyLight (Wet AMD) - HREC/70671/SVHM-2021-263810
- Talon EXTN (Wet AMD) - HREC/67626/SVHM-2020-232811
- HORIZON (Dry AMD) - SVHM HREC 294/20
- AVONELLE-X (Extension of Lucerne) - HREC/72069/SVHM-2020-244368
- COMINO (CRVO) - HREC/65387/SVHM-2020-219227
- SAPPHIRE (RVO) - HREC/17/POWH/178
- TOPAZ (RVO) - HREC/18/MH/103
- RAVEN (CRVO) - HREC/51264/SVHM-2019
- RIPPLE (RVO) - HREC/67565/SVHM-2020-226369
- BALATON (BRVO) - HREC/65076/SVHM-2020-230166
- NIRVO (RVO) - HREC/61973/SVHM-2020
- AUSSIEDEX - HREC/16/RAH/250
- SwitchDMO Study - HREC/12/RPAH/547
- Genetic study of Diabetic Retinopathy - SESLHD HREC 08/213
- NIRD - HREC/14/RPAH/205
- Bevordex (DMO) - LNR/17/POWH/619
- Ladamo (DMO) - HREC/14/RPAH/204
- Kestrel (DMO) - HREC/18/SVHM/149
- RHINE (DMO) - HREC/18/SVHM/240
- RIPPLE (DMO) - HREC/67565/SVHM-2020-226369
- CANBERRA - HREC/68388/SVHM-2020-230633
- RHONE-X (Extension of Rhine) - HREC/63535/SVHM-2020
- MacTel Bilateral - SCGOPHCG HREC RGS0000004826
- MacTel CNTF2 - HREC/13/RPAH/393
- RENEXUS - HREC/17/SVHM/192
- ONL1204 - HREC/50110/SVHM-2018